DNA Microarray Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The DNA Microarray Market Report is Segmented by Type (cDNA Microarrays, Oligonucleotide Microarrays, and Other Types), by Application (Gene Expression Analysis, Genotyping, and Other Applications), by End User (Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Centers, and Research and Academic Institutes) and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

DNA Microarray Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

DNA Microarray Market Size

DNA Microarray Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 1.81 Billion
Market Size (2030) USD 2.77 Billion
CAGR (2025 - 2030) 8.89 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

DNA Microarray Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of DNA Microarray Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

DNA Microarray Market Analysis

The DNA Microarray Market size is estimated at USD 1.81 billion in 2025, and is expected to reach USD 2.77 billion by 2030, at a CAGR of 8.89% during the forecast period (2025-2030).

A DNA microarray is a powerful biotechnology tool used to analyze the expression of thousands of genes simultaneously. It consists of a small glass or silicon chip with thousands of microscopic spots, each containing a specific DNA sequence that can hybridize with complementary RNA or DNA from a sample. Researchers utilize DNA microarrays for applications such as gene expression profiling, genotyping, and disease diagnostics.

The DNA microarray market is primarily driven by several key factors. The increasing prevalence of genetic disorders and the growing emphasis on personalized medicine are propelling the demand for advanced diagnostic tools. For instance, according to the data published by the Centers for Disease Control and Prevention (CDC) in July 2023, the estimated prevalence of hemophilia in the United States is 12 cases per 100,000 in the United States males for hemophilia A and 3.7 cases per 100,000 in the United States males for hemophilia B. 

Thus, the high prevalence of hemophilia leads to increase the demand for genetic testing and personalized treatment options, driving the need for advanced diagnostic tools like DNA microarrays. These microarrays facilitate rapid, high-throughput screening for genetic mutations associated with the disease, thereby enhancing early detection and management strategies.

Furthermore, technological advancements in microarray platforms, including enhanced sensitivity and resolution, are also contributing to market growth. For instance, in March 2024, Nucleus Genomics, Inc., the next-generation genetic testing and analysis company launched its DNA analysis product to bring the benefits of personalized medicine to everyone. Such initiatives not only bolster individual healthcare management but also amplify interest in genomic research and personalized medicine. As a result, there's a growing demand for DNA microarrays, with both consumers and healthcare providers increasingly pursuing advanced genetic testing solutions.

Additionally, in June 2023, MARGenomics, a core facility at IMIM (Hospital del Mar Medical Research Institute), launched the Applied Biosystems GeneChip 3000 Dx v2. This advanced microarray platform, funded by the Carlos III Health Institute (ISCIII) and the European Union's NextGenerationEU program, highlighted its reliability and use in clinical settings. The platform helped healthcare providers include advanced genomic testing in patient care, creating more market opportunities. This launch is anticipated to boost the DNA microarray market by meeting the growing need for precision medicine and personalized treatments.

Moreover, the rising investments in genomic research and biotechnology, along with the expansion of applications in drug discovery and molecular diagnostics, further bolster the market. For instance, in June 2024, Genome Canada and Genome Alberta allocated USD 1 million to GlycoNet Integrated Services (GIS) to enhance glycomics services, targeting health, agriculture, and bio-based industries. With glycomics playing a pivotal role in personalized medicine and agricultural biotechnology, the demand for DNA microarrays tools that dissect these intricate interactions is on the rise. This alignment not only propels innovation within the DNA microarray market but also paves the way for novel applications and research avenues.

Hence, the factors above, such as increasing prevalence of genetic disorders, technological advancements in microarray platforms, and rising investments in genomic research contribute to the market growth during the forecast period. However, the rising adoption of next-generation sequencing and other alternative technologies, despite their high costs, is becoming prominent in clinical genetic research, which could impede market growth.

DNA Microarray Industry Overview

The DNA microarray market is semi-consolidated and consists of several major players. Most of these significant players enjoy a global presence and face intense competition in emerging economies. Emerging countries are becoming hotspots for substantial competition due to the rapidly expanding market fueled by increasing genetic testing for personalized treatment. Some market players are Thermo Fisher Scientific Inc., Toray Industries, Inc., Illumina, Inc., Agilent Technologies, Inc., PerkinElmer Inc., QIAGEN, Applied Micro Arrays, Bio-Rad Laboratories, Inc., Merck KGaA, and BIOMÉRIEUX.

DNA Microarray Market Leaders

  1. Thermo Fisher Scientific Inc.

  2. Illumina, Inc.

  3. Agilent Technologies, Inc.

  4. PerkinElmer Inc.

  5. Applied Micro Arrays

  6. *Disclaimer: Major Players sorted in no particular order
DNA Microarray Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

DNA Microarray Market News

  • March 2024: Nucleus Genomics, Inc. launched a DNA analysis product that democratized access to personalized medicine. This innovation allows individuals to understand their genetic profiles better, enabling them to make informed health and wellness decisions.
  • January 2024: Thermo Fisher Scientific, Inc. launched its PangenomiX Array, a leap forward in DNA microarray technology. This cutting-edge platform empowers extensive population-scale disease studies and pharmacogenomics research. By bolstering the analysis of genetic variations in diverse populations, it paves the way for more tailored approaches in personalized medicine.

DNA Microarray Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Need for Personalized Medicine Amid High Burden of Genetic Disorders and Cancers
    • 4.2.2 Increasing Medical Research
  • 4.3 Market Restraints
    • 4.3.1 High Cost and Increasing Competition from Alternative Technologies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product
    • 5.1.1 cDNA Microarrays
    • 5.1.2 Oligonucleotide Microarrays
    • 5.1.3 Other Types (BAC Microarrays and SNP Microarrays)
  • 5.2 By Application
    • 5.2.1 Gene Expression Analysis
    • 5.2.2 Genotyping
    • 5.2.3 Other Applications (Epigenetics and Pathogen Detection)
  • 5.3 By End User
    • 5.3.1 Pharmaceutical and Biotechnology Companies
    • 5.3.2 Hospitals and Diagnostic Centers
    • 5.3.3 Research and Academic Institutes
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific Inc.
    • 6.1.2 TORAY INDUSTRIES, INC.
    • 6.1.3 Illumina, Inc.
    • 6.1.4 Agilent Technologies, Inc.
    • 6.1.5 PerkinElmer Inc.
    • 6.1.6 QIAGEN
    • 6.1.7 Schott AG (Applied Micro Arrays)
    • 6.1.8 Bio-Rad Laboratories, Inc.
    • 6.1.9 BIOMRIEUX
    • 6.1.10 Merck KGaA
    • 6.1.11 F. Hoffmann-La Roche Ltd.
    • 6.1.12 Arryait Corporation (ARYC)
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

DNA Microarray Industry Segmentation

As per the scope of the report, DNA microarray is a laboratory tool used to detect the expression of thousands of genes simultaneously by hybridizing labeled RNA or DNA samples to complementary DNA probes fixed on a solid surface. This technique allows researchers to analyze gene expression patterns and study genetic variations across different conditions or treatments.

The DNA microarray market is segmented by type, application, end user, and geography. By type, the market is segmented into cDNA microarrays, oligonucleotide microarrays, and other types. The other types are further segmented into BAC microarrays and SNP microarrays. By application, the market is segmented into gene expression analysis, genotyping, and other applications. The other applications are further segmented into epigenetics and pathogen detection. By end user, the market is segmented into pharmaceutical and biotechnology companies, hospitals and diagnostic centers, and research and academic institutes. The report also covers the market size and forecasts for the DNA microarray market in 17 countries across major regions. For each segment, the market sizing and forecasts have been done on the basis of value (USD).

By Product cDNA Microarrays
Oligonucleotide Microarrays
Other Types (BAC Microarrays and SNP Microarrays)
By Application Gene Expression Analysis
Genotyping
Other Applications (Epigenetics and Pathogen Detection)
By End User Pharmaceutical and Biotechnology Companies
Hospitals and Diagnostic Centers
Research and Academic Institutes
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

DNA Microarray Market Research FAQs

How big is the DNA Microarray Market?

The DNA Microarray Market size is expected to reach USD 1.81 billion in 2025 and grow at a CAGR of 8.89% to reach USD 2.77 billion by 2030.

What is the current DNA Microarray Market size?

In 2025, the DNA Microarray Market size is expected to reach USD 1.81 billion.

Who are the key players in DNA Microarray Market?

Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., PerkinElmer Inc. and Applied Micro Arrays are the major companies operating in the DNA Microarray Market.

Which is the fastest growing region in DNA Microarray Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in DNA Microarray Market?

In 2025, the North America accounts for the largest market share in DNA Microarray Market.

What years does this DNA Microarray Market cover, and what was the market size in 2024?

In 2024, the DNA Microarray Market size was estimated at USD 1.65 billion. The report covers the DNA Microarray Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the DNA Microarray Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

DNA Microarray Industry Report

Statistics for the 2025 DNA Microarray market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. DNA Microarray analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.